Back to search results

Prophylactic Treatment With Atorvastatin for Episodic Migraine.

Abroad (travel likely)RecruitingPHASE2

Conditions

Episodic Migraine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Haukeland University Hospital, Bergen, Norway

    Contact: Study coordinator (Marte-Helene Bjørk, Professor) · Marte.Bjork@uib.no

  • University Hospital, Akershus, Lørenskog, Norway

    Contact: Study coordinator (Kjersti G Vetvik, Ph.d.) · kjersti.grotta.vetvik2@ahus.no

  • Oslo University Hospital, Rikshospitalet, Oslo, Norway

    Contact: Study coordinator (Anne H Aamodt, Senior researcher) · a.h.aamodt@medisin.uio.no

  • Oslo University Hospital, Ullevål, Oslo, Norway

    Contact: Study coordinator (Bendik S Windsvold, Post.doc.) · bendik.s.winsvold@gmail.com

  • University Hospital Northern Norway, Tromsø, Norway

    Contact: Study coordinator (Linn H Steffensen, Associate Professor II) · linn.steffensen@unn.no

  • St. Olavs hospital, Trondheim, Norway

    Contact: Study coordinator (Lise R Øie, Post.doc) · lise.r.oie@ntnu.no · 41419596
    Contact: Study coordinator (Joakim H. Østhus, Cand.med) · Joakim.h.osthus@ntnu.no · 93837036
Study leads

  • Marte-Helene Bjørk, Professor

    Principal Investigator

    Haukeland University Hospital

  • Kjersti G Vetvik, Ph.d.

    Principal Investigator

    University Hospital, Akershus

  • Bendik S Winsvold, Post.doc.

    Principal Investigator

    Oslo University Hospital, Ullevål

  • Anne H Aamodt, Senior researcher

    Principal Investigator

    Oslo University Hospital

  • Lise R Øie, Post.doc.

    Principal Investigator

    St. Olavs Hospital

  • Linn H Steffensen, Associate Professor II

    Principal Investigator

    University Hospital Northern Norway

View source on ClinicalTrials.gov(opens in a new tab)